Abstract:Objective: Preeclampsia (PE) is a significant cause of maternal and offspring mortality and morbidity. The purpose of this study is to identify the potential diagnostic signatures of autophagy-related genes (ATGs) in pregnancies with preeclampsia. Methods: The expression profile of mRNA was obtained from GSE75010 (placenta samples) and GSE48424 dataset (blood samples). The potential differentially expressed ATGs of PE were screened by R software. The gene-ontology (GO) enrichment analysis, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis, correlation analysis, and protein-protein interactions (PPI) were applied for the differentially expressed ATGs. The diagnostic markers of PE were then screened based on least absolute shrinkage and selection operator (LASSO) logistic regression and support vector machine-recursive feature elimination (SVM-RFE). Receiver operating characteristic (ROC) analysis was used to investigate the predictive value of these diagnostic markers. Target miRNAs were predicted based on the miRDB, DIANA-micro T, Targetscan, and miRWalk databases, and were further validated in GSE84260. Results: A total of 20 differentially expressed ATGs were identified between PE and healthy pregnancies. Functional analysis of differentially expressed ATGs indicated several enriched terms related to autophagy, apoptosis, angiogenesis, inflammation, immune response, hypoxia-inducible factor 1 (HIF-1), forkhead box O (FoxO) and AMP-activated protein kinase (AMPK) signaling pathway. A total of 12 ATGs were recognized based on LASSO and SVM-RFE, which made an excellent distinction in both the placenta tissues (area under the curve [AUC] = 0.903) and the blood samples (AUC = 0.972). Furthermore, four feature ATGs (leptin [LEP], ERO1-like [ERO1L], phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [PIK3CB], and mitogen-activated protein kinase 8 [MAPK8]) were screened and also shown an excellent diagnostic efficacy (AUC = 0.869 in placenta samples, and AUC = 0.914 in blood samples). Additionally, 81 target miRNAs were predicted according to the 4 feature ATGs. After evaluating the miRNA expression pattern of GSE84260, 11 miRNAs were selected. Finally, a miRNA-mRNA regulatory network was constructed, which may participate in the development of PE. Conclusions: We established an autophagy-related-gene based signature that may predict pregnancies with PE. And we also constructed a miRNA-mRNA regulatory network, which may deepen our understanding of the molecular mechanism underlying the development of PE.

Pathogenic Mechanisms of Preeclampsia with Severe Features Implied by the Plasma Exosomal Mirna Profile

Maternal Plasma Mirnas Expression in Preeclamptic Pregnancies

Identification of differentially expressed miRNAs in plasma exosomes from patients with early-onset pre-eclampsia using next generation sequencing

Bioinformatics-based Identification of Mirna-, Lncrna-, and Mrna-Associated Cerna Networks and Potential Biomarkers for Preeclampsia.

High Throughput Sequencing Analysis of Exosomal miRNA Expressions in Early-Onset Preeclampsia Patients

Profiling of Exosomal Micrornas Expression in Umbilical Cord Blood from Normal and Preeclampsia Patients

Small RNA sequencing reveals placenta-derived exosomal microRNAs associated with preeclampsia

Deregulated microRNA species in the plasma and placenta of patients with preeclampsia.

Integrated analysis of microRNA and mRNA expression profiles in Preeclampsia

Placenta-derived exosomes as carriers of non-coding RNAs in maternal circulation of patients with preeclampsia

Exploring the role of exosomal MicroRNAs as potential biomarkers in preeclampsia

Placenta-Specific Circulating Mircornas and Their Variants As Potential Biomarkers for Preeclampsia

Placental Exosomal Mir-125B Triggered Endothelial Barrier Injury in Preeclampsia.

Transfer of Mir-15A-5p by Placental Exosomes Promotes Pre-Eclampsia Progression by Regulating PI3K/AKT Signaling Pathway Via CDK1.

Differential Expression Of Micrornas In The Placentae Of Chinese Patients With Severe Pre-Eclampsia

The aberrantly expressed miR-193b-3p contributes to preeclampsia through regulating transforming growth factor-β signaling

Variations of MicroRNAs in Human Placentas and Plasma from Preeclamptic Pregnancy

A Potential Autophagy-Related-Gene Based Signature in Patients with Preeclampsia

Research progress of exosomes in pathogenesis and treatment of preeclampsia

Placenta-Derived MicroRNAs in the Pathophysiology of Human Pregnancy

Exosomal Encapsulation of Mir-125A-5p Inhibited Trophoblast Cell Migration and Proliferation by Regulating the Expression of VEGFA in Preeclampsia.